Gulf International Bank (UK)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-21,968
Closed -$556K 692
2022
Q3
$556K Hold
21,968
0.01% 612
2022
Q2
$754K Buy
21,968
+145
+0.7% +$6.16K 0.01% 600
2022
Q1
$1.57M Sell
21,823
-200
-0.9% -$14.4K 0.02% 532
2021
Q4
$2.02M Sell
22,023
-5,500
-20% -$657K 0.03% 505
2021
Q3
$3.49M Sell
27,523
-133
-0.5% -$19.4K 0.04% 421
2021
Q2
$4.6M Buy
27,656
+2,685
+11% +$435K 0.06% 337
2021
Q1
$4.54M Sell
24,971
-3,797
-13% -$881K 0.06% 318
2020
Q4
$5.75M Buy
28,768
+10,261
+55% +$2.09M 0.08% 274
2020
Q3
$4.06M Buy
18,507
+827
+5% +$175K 0.06% 315
2020
Q2
$3.37M Buy
+17,680
New +$3.1M 0.05% 343

Other funds holding TDOC

Gulf International Bank (UK)'s TDOC Position: Q4 2022 in Review

Gulf International Bank (UK) sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 21,968 shares — an estimated $556K sold.

Gulf International Bank (UK) first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $5.75M in Q4 2020. 444 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Gulf International Bank (UK) reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Gulf International Bank (UK) sold 21,968 Teladoc Health shares in Q4 2022, an estimated $556K.
  • Gulf International Bank (UK) first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Gulf International Bank (UK)'s Teladoc Health position peaked at $5.75M in Q4 2020.
  • 444 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Gulf International Bank (UK)'s 13F filing for Q4 2022, filed 8 Feb 2023.